UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype

European respiratory review, 2018-12, Vol.27 (150), p.180077

2018

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends

Scientific reports, 2021-03, Vol.11 (1), p.4897-4897, Article 4897

2021

Link zum Volltext

Verfügbarkeit prüfen

Prospective Use of Descriptors of Dyspnea to Diagnose Common Respiratory Diseases

Chest, 2015-10, Vol.148 (4), p.895-902

2015

Link zum Volltext

Verfügbarkeit prüfen

Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry

Annals of internal medicine, 2014-08, Vol.161 (4), p.233

2014

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD

Chest, 2011-08, Vol.140 (2), p.351-358

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of Increased Blood Levels of β-Endorphin on Perception of Breathlessness

Chest, 2013-05, Vol.143 (5), p.1378-1385

2013

Link zum Volltext

Verfügbarkeit prüfen

Calprotectin-mediated zinc chelation inhibits Pseudomonas aeruginosa protease activity in cystic fibrosis sputum

Journal of bacteriology, 2021-06, Vol.203 (13)

2021

Link zum Volltext

Verfügbarkeit prüfen

Reducing treatment burden in the era of CFTR modulators – Authors' reply

The lancet respiratory medicine, 2023-09, Vol.11 (9), p.e79-e79

2023

Link zum Volltext

Verfügbarkeit prüfen

Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA

mSphere, 2018-08, Vol.3 (4)

2018

Link zum Volltext

Verfügbarkeit prüfen

Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy

Journal of cystic fibrosis, 2020-09, Vol.19 (5), p.762-767

2020

Link zum Volltext

Verfügbarkeit prüfen

CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis

Annals of the American Thoracic Society, 2019-03, Vol.16 (3), p.331-340

2019

Link zum Volltext

Verfügbarkeit prüfen

Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture

Journal of bacteriology, 2020-01, Vol.202 (2), p.1

2020

Link zum Volltext

Verfügbarkeit prüfen

Neuromodulatory Effect of Endogenous Opioids on the Intensity and Unpleasantness of Breathlessness during Resistive Load Breathing in COPD

Chronic obstructive pulmonary disease, 2011-06, Vol.8 (3), p.160-166

2011

Link zum Volltext

Verfügbarkeit prüfen

Update on Clinical Outcomes of Highly Effective Modulator Therapy

Clinics in chest medicine, 2022-12, Vol.43 (4), p.677

2022

Link zum Volltext

Verfügbarkeit prüfen

Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis

Pediatric pulmonology, 2021-07, Vol.56 (7), p.2048-2056

2021

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive ventilation as a palliative measure

Current opinion in supportive & palliative care, 2014-09, Vol.8 (3), p.218

Gifford, Alex H

2014

Link zum Volltext

Verfügbarkeit prüfen

Does Ivacaftor Taken Twice a Day Keep the Pseudomonas Away?

Annals of the American Thoracic Society, 2019-11, Vol.16 (11), p.1366-1367

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler

Journal of aerosol medicine and pulmonary drug delivery, 2013-06, Vol.26 (3), p.174

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs

Journal of cystic fibrosis, 2021-12, Vol.20, p.9-13

2021

Link zum Volltext

Verfügbarkeit prüfen

The cost of simplifying treatments for cystic fibrosis: Implications of the SIMPLIFY trial

Journal of managed care & specialty pharmacy, 2024-01, Vol.30 (1), p.26

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate

Journal of aerosol medicine and pulmonary drug delivery, 2014-04, Vol.27 (2), p.103

2014

Link zum Volltext

Verfügbarkeit prüfen

Perspectives on anemia and iron deficiency from the cystic fibrosis care community

Pediatric pulmonology, 2019-07, Vol.54 (7), p.939-940

2019

Link zum Volltext

Verfügbarkeit prüfen

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

Journal of cystic fibrosis, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis

Journal of cystic fibrosis, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Humans
(34)
Respiratory System
(26)
Cystic Fibrosis
(23)
Male
(22)
Female
(21)
Middle Aged
(15)
Adult
(14)
Aged
(12)
General & Internal Medicine
(11)
Critical Care Medicine
(9)
Pulmonary Disease, Chronic Obstructive - Physiopathology
(8)
Pulmonary/respiratory
(8)
Young Adult
(8)
Adolescent
(7)
Cystic Fibrosis - Drug Therapy
(6)
Sputum
(6)
Treatment Outcome
(6)
Biological And Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype

A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends

Prospective Use of Descriptors of Dyspnea to Diagnose Common Respiratory Diseases

Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry

Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD

Effect of Increased Blood Levels of β-Endorphin on Perception of Breathlessness

Calprotectin-mediated zinc chelation inhibits Pseudomonas aeruginosa protease activity in cystic fibrosis sputum

Reducing treatment burden in the era of CFTR modulators – Authors' reply

Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA

Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy

CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis

Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture

Neuromodulatory Effect of Endogenous Opioids on the Intensity and Unpleasantness of Breathlessness during Resistive Load Breathing in COPD

Update on Clinical Outcomes of Highly Effective Modulator Therapy

Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis

Noninvasive ventilation as a palliative measure

Does Ivacaftor Taken Twice a Day Keep the Pseudomonas Away?

Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler

Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs

The cost of simplifying treatments for cystic fibrosis: Implications of the SIMPLIFY trial

Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate

Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis Study

Perspectives on anemia and iron deficiency from the cystic fibrosis care community

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis

Suchergebnisse filtern